Dual treatment with shikonin and temozolomide reduces glioblastoma tumor growth, migration and glial-to-mesenchymal transition
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dual treatment with shikonin and temozolomide reduces glioblastoma tumor growth, migration and glial-to-mesenchymal transition
Authors
Keywords
Glioblastoma, Shikonin, Temozolomide, Migration, Glial-to-mesenchymal transition
Journal
CELLULAR ONCOLOGY
Volume 40, Issue 3, Pages 247-261
Publisher
Springer Nature
Online
2017-04-11
DOI
10.1007/s13402-017-0320-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epithelial-mesenchymal transition in glioblastoma progression
- (2016) YASUO IWADATE Oncology Letters
- Small-molecule inhibitors of FGFR, integrins and FAK selectively decrease L1CAM-stimulated glioblastoma cell motility and proliferation
- (2016) Hannah J. Anderson et al. CELLULAR ONCOLOGY
- Role of EMT in Metastasis and Therapy Resistance
- (2016) Bethany Smith et al. Journal of Clinical Medicine
- Tamoxifen in combination with temozolomide induce a synergistic inhibition of PKC-pan in GBM cell lines
- (2015) Joana Balça-Silva et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Flavonoids suppress human glioblastoma cell growth by inhibiting cell metabolism, migration, and by regulating extracellular matrix proteins and metalloproteinases expression
- (2015) Balbino L. Santos et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Shikonin and its derivatives inhibit the epidermal growth factor receptor signaling and synergistically kill glioblastoma cells in combination with erlotinib
- (2015) Qiaoli Zhao et al. INTERNATIONAL JOURNAL OF CANCER
- Shikonin as an inhibitor of the LPS-induced epithelial-to-mesenchymal transition in human breast cancer cells
- (2015) DARONG HONG et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Shikonin Inhibits the Migration and Invasion of Human Glioblastoma Cells by Targeting Phosphorylated β-Catenin and Phosphorylated PI3K/Akt: A Potential Mechanism for the Anti-Glioma Efficacy of a Traditional Chinese Herbal Medicine
- (2015) Feng-Ying Zhang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Epithelial-to-mesenchymal transition in paired human primary and recurrent glioblastomas
- (2015) CAROLIN KUBELT et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Vimentin contributes to epithelial-mesenchymal transition cancer cell mechanics by mediating cytoskeletal organization and focal adhesion maturation
- (2015) Ching-Yi Liu et al. Oncotarget
- Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways
- (2014) Yongqiang Chen et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- FibrilTool, an ImageJ plug-in to quantify fibrillar structures in raw microscopy images
- (2014) Arezki Boudaoud et al. Nature Protocols
- Sensitizing the Therapeutic Efficacy of Taxol with Shikonin in Human Breast Cancer Cells
- (2014) Wenjuan Li et al. PLoS One
- Integrin inhibition promotes atypical anoikis in glioma cells
- (2014) M Silginer et al. Cell Death & Disease
- Equinatoxin II Potentiates Temozolomide- and Etoposide-Induced Glioblastoma Cell Death
- (2013) Suzana Assad Kahn et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Shikonin Suppresses the Migratory Ability of Hepatocellular Carcinoma Cells
- (2013) Po-Li Wei et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Sustained elevation of Snail promotes glial-mesenchymal transition after irradiation in malignant glioma
- (2013) Roshan Mahabir et al. NEURO-ONCOLOGY
- Anticancer Agent Shikonin Is an Incompetent Inducer of Cancer Drug Resistance
- (2013) Hao Wu et al. PLoS One
- Connective Tissue Growth Factor (CTGF/CCN2) Is Negatively Regulated during Neuron-Glioblastoma Interaction
- (2013) Luciana F. Romão et al. PLoS One
- Topoisomerase I Inhibitors, Shikonin and Topotecan, Inhibit Growth and Induce Apoptosis of Glioma Cells and Glioma Stem Cells
- (2013) Feng-Lei Zhang et al. PLoS One
- Shikonin attenuates lung cancer cell adhesion to extracellular matrix and metastasis by inhibiting integrin β1 expression and the ERK1/2 signaling pathway
- (2013) Heyong Wang et al. TOXICOLOGY
- Glioblastoma: Therapeutic challenges, what lies ahead
- (2012) Flavia R.S. Lima et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- TPPP acts downstream of RhoA-ROCK-LIMK2 to regulate astral microtubule organization and spindle orientation
- (2012) Y.-W. Heng et al. JOURNAL OF CELL SCIENCE
- A Multi-Cancer Mesenchymal Transition Gene Expression Signature Is Associated with Prolonged Time to Recurrence in Glioblastoma
- (2012) Wei-Yi Cheng et al. PLoS One
- The Epithelial-Mesenchymal Transition (EMT) Regulatory Factor SLUG (SNAI2) Is a Downstream Target of SPARC and AKT in Promoting Melanoma Cell Invasion
- (2012) Nina Fenouille et al. PLoS One
- Matrix metalloproteinase-2 Promotes αvβ3 Integrin-Mediated Adhesion and Migration of Human Melanoma Cells by Cleaving Fibronectin
- (2012) Yang Jiao et al. PLoS One
- Overcoming Temozolomide Resistance in Glioblastoma via Dual Inhibition of NAD+ Biosynthesis and Base Excision Repair
- (2011) E. M. Goellner et al. CANCER RESEARCH
- Targeting the AKT Pathway in Glioblastoma
- (2011) Kelli A. McDowell et al. CURRENT PHARMACEUTICAL DESIGN
- aV integrins and TGF-β-induced EMT: a circle of regulation
- (2011) Fahmy A. Mamuya et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Potentiation of anticancer-drug cytotoxicity by sea anemone pore-forming proteins in human glioblastoma cells
- (2010) Rossana C. Soletti et al. ANTI-CANCER DRUGS
- MMP-2 alters VEGF expression via αVβ3 integrin-mediated PI3K/AKT signaling in A549 lung cancer cells
- (2009) Chandramu Chetty et al. INTERNATIONAL JOURNAL OF CANCER
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now